11th Annual North Carolina Research Triangle Pulmonary Hypertension Symposium

November 1, 2019

Learning Objectives

Describe classification of Pulmonary Hypertension, according to the World Symposium classifications and including updates from the 6th World Symposium, as well as the treatment options with respect to PAH-specific therapies

Recognize and distinguish similar disease processes that may or may not respond to Pulmonary Arterial Hypertension specific therapy

Identify various PH subtypes and explain their diagnosis and clinical course, particularly PH associated the hematologic disorders and portopulmonary hypertension

Describe the importance of screening for CTEPH and referral for definitive therapy, as well as gain knowledge on new developments in the field of CTEPH

Identify the role of clinical trials in the development of new PAH therapies, with a particular appreciation of the patient perspective as a clinical trial subject

describe the importance of screening for CTEPH and referral for definitive therapy, as well as gain knowledge on new developments in the field of CTEPH

Express how the evolving field of precision medicine applies to the current and future state of PAH diagnosis and treatment

Recognize the importance of nonpharmacologic interventions such as cardiac/pulmonary rehab. 

Course summary
Available credit: 
  • 6.50 ACPE - Pharmacist
  • 6.50 AMA PRA Category 1 Credit(s)
  • 6.50 ANCC
  • 6.50 Attendance
Registration Opens: 
11/01/2019
Registration Expires: 
12/02/2021
Activity Starts: 
11/01/2019 - 8:00am
Activity Ends: 
11/01/2019 - 4:00pm
Rating: 
0
Durham, NC
United States

Available Credit

  • 6.50 ACPE - Pharmacist
  • 6.50 AMA PRA Category 1 Credit(s)
  • 6.50 ANCC
  • 6.50 Attendance
Please login or register to take this course.